NMN and NAD⁺ have become one of the most-discussed subjects in longevity science — reported on by major publications and studied in peer-reviewed journals around the world. Here is a selection of that coverage, with links to read each in full.
These articles report on NMN and NAD⁺ — the compound and the science behind our formula — not on Sigma Formulas. Coverage refers to the research, not an endorsement of any product. Links open on each publisher's own website.
In the press
National GeographicFeatureDo NAD⁺ supplements work to promote longevity? Here's what the experts say.Read on nationalgeographic.com → NPRReportMarketers say NAD⁺ pills and infusions can boost longevity. What's the evidence?Read on npr.org → ScienceDailyNewsScientists say NAD⁺ could slow aging and help fight Alzheimer's and Parkinson's.Read on sciencedaily.com → Harvard GazetteUniversityHarvard scientists pinpoint a critical step in DNA repair and cellular aging — centred on NAD⁺.Read on harvard.edu → Harvard Medical SchoolUniversityUnraveling the mysteries of aging — the role of NAD⁺ and sirtuins.Read on hms.harvard.edu →In the peer-reviewed journals
NatureJournalRecent research into nicotinamide mononucleotide and ageing.Read on nature.com → Frontiers in AgingJournal · Human trialThe UTHEVER® NMN human study — a multicentre, randomised, double-blind, placebo-controlled trial in middle-aged and older adults. This is the ingredient we use.Read the trial on frontiersin.org →Publications and journals are the property of their respective owners and are referenced here for informational purposes only. This page is educational and does not constitute medical advice. *These statements have not been evaluated by the FDA. NMN+ is not intended to diagnose, treat, cure, or prevent any disease.